Their reverse-phase protein array (RPPA) and Western blot analysis also revealed that miR-6126 overexpression reduced PI3K/AKT pathway signaling in multiple ovarian cancer cell lines. The gene discussed is AKT1; the disease is ovarian carcinoma.